Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,594 EUR | +6.27% |
|
-2.15% | -5.42% |
06-26 | Singapore port congestion shows global ripple impact of Red Sea attacks | RE |
06-26 | Singapore port congestion shows global ripple impact of Red Sea attacks | RE |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The stock, which is currently worth 2024 to 3.66 times its sales, is clearly overvalued in comparison with peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- Low profitability weakens the company.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Marine Freight & Logistics
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.42% | 27.04B | - | ||
+72.23% | 31.84B | A- | ||
+27.48% | 32.38B | A- | ||
+7.12% | 13.05B | B | ||
+6.66% | 10.75B | B- | ||
+15.69% | 10.51B | B | ||
-2.91% | 9.72B | A- | ||
+16.03% | 9.6B | B- | ||
+38.61% | 9.13B | B- | ||
+8.36% | 8.42B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MAERSK B Stock
- MRSA Stock
- Ratings AP Moller Maersk